Cargando…
Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report
BACKGROUND: A novel immunodeficiency, frequently accompanied by high serum-IgE, and caused by mutations in the PGM3 gene was described in 2014. To date there are no unique phenotype characteristics for PGM3 deficiency. PGM3 encodes a carbohydrate-modifying enzyme, phosphoglucomutase 3. Null-mutation...
Autores principales: | Lundin, Karin E., Wang, Qing, Hamasy, Abdulrahman, Marits, Per, Uzunel, Mehmet, Wirta, Valtteri, Wikström, Ann-Charlotte, Fasth, Anders, Ekwall, Olov, Smith, C.I. Edvard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114780/ https://www.ncbi.nlm.nih.gov/pubmed/30157810 http://dx.doi.org/10.1186/s12887-018-1258-9 |
Ejemplares similares
-
Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene
por: Lundin, Karin E., et al.
Publicado: (2015) -
First Year of TREC-Based National SCID Screening in Sweden
por: Göngrich, Christina, et al.
Publicado: (2021) -
Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defects
por: Hammarsten, Ola, et al.
Publicado: (2022) -
Just ten percent of the global terrestrial protected area network is structurally connected via intact land
por: Ward, Michelle, et al.
Publicado: (2020) -
Challenges in estimating percent inclusion of alternatively spliced junctions from RNA-seq data
por: Kakaradov, Boyko, et al.
Publicado: (2012)